Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 430,196	$ 373,173
Accounts receivable, net of allowances of approximately $13.7 million and $17.6 million at March 31, 2016 and December 31, 2015	42,834	52,328
Inventory	68,454	64,584
Prepaid expenses and other current assets	19,337	19,995
Current assets held for sale	0	322,837
Total current assets	560,821	832,917
Fixed assets, net	34,416	34,780
Intangible assets, net	629,935	636,220
Goodwill	289,441	289,441
Restricted cash	1,406	1,428
Contingent purchase price from sale of business	78,000	0
Other assets	750	730
Total assets	1,594,769	1,795,516
Current liabilities:
Accounts payable	15,526	36,038
Accrued expenses	103,109	128,558
Current portion of contingent purchase price	29,939	26,800
Convertible senior notes	258,800	255,473
Deferred revenue	21,869	19,863
Current liabilities held for sale	0	67,515
Total current liabilities	429,243	534,247
Contingent purchase price	89,673	96,957
Convertible senior notes	315,080	312,107
Deferred tax liabilities	89,150	89,996
Other liabilities	12,530	13,346
Total liabilities	935,676	1,046,653
Equity component of currently redeemable convertible senior notes (Note 10)	14,167	17,089
Stockholders’ equity:
Preferred stock, $1.00 par value per share, 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value per share; 187,500,000 authorized, 72,131,960 issued and 69,938,978 outstanding at March 31, 2016 and 71,767,371 issued and 69,574,389 outstanding at December 31, 2015	72	72
Additional paid-in capital	1,223,024	1,208,058
Treasury stock, at cost; 2,192,982 shares at March 31, 2016 and December 31, 2015	(50,000)	(50,000)
Accumulated deficit	(522,313)	(429,865)
Accumulated other comprehensive (loss) income	(5,377)	3,973
Total The Medicines Company stockholders’ equity	645,406	732,238
Non-controlling interest in joint venture	(480)	(464)
Total stockholders’ equity	644,926	731,774
Total liabilities and stockholders’ equity	$ 1,594,769	$ 1,795,516